Inventor · disambiguated record
Niall Morrison Barr Martin
Also filed as: MARTIN NIALL · MARTIN NIALL M B · MARTIN NIALL MORRISON BARR
32 granted patents·19 pending applications·472 citations·filing 2001–2023
97Inventor score
Top patents by PatentIndex Score
51 records- 0197US7449464B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2004·Granted Nov 11, 2008·69 cites·2 claims
- 0295US7662818B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2005·Granted Feb 16, 2010·20 cites·7 claims
- 0394US8101602B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsMENEAR KEITH·Filed 2011·Granted Jan 24, 2012·19 cites·9 claims
- 0494US6664269B2Isoquinolinone derivativesMAYBRIDGE PLC·Filed 2002·Granted Dec 16, 2003·98 cites·10 claims
- 0592US8143241B2DNA damage repair inhibitors for treatment of cancerASHWORTH ALAN·Filed 2005·Granted Mar 27, 2012·19 cites·19 claims
- 0692US7151102B2Phthalazinone derivativesMAYBRIDGE PLC·Filed 2001·Granted Dec 19, 2006·55 cites·8 claims
- 0790US9102670B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2013·Granted Aug 11, 2015·5 cites·6 claims
- 0890US7402607B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2005·Granted Jul 22, 2008·16 cites·13 claims
- 0988US8129380B2Phthalazinone derivativesMENEAR KEITH ALLAN·Filed 2009·Granted Mar 6, 2012·22 cites·11 claims
- 1088US7750006B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2006·Granted Jul 6, 2010·7 cites·2 claims
- 1187US9566276B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2015·Granted Feb 14, 2017·4 cites·12 claims
- 1287US7470688B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2006·Granted Dec 30, 2008·10 cites·14 claims
- 1386US9169235B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2014·Granted Oct 27, 2015·5 cites·12 claims
- 1486US8435985B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsMENEAR KEITH·Filed 2011·Granted May 7, 2013·3 cites·8 claims
- 1585US8912187B2Phthalazinone derivativesMARTIN NIALL MORRISON BARR·Filed 2011·Granted Dec 16, 2014·9 cites·12 claims
- 1685US7196085B2Phthalazinone derivativesMAYBRIDGE PLC·Filed 2003·Granted Mar 27, 2007·43 cites·29 claims
- 1785US7049313B2ATM inhibitorsKUDOS PHARM LTD·Filed 2003·Granted May 23, 2006·19 cites·9 claims
- 1884US10449192B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2018·Granted Oct 22, 2019·2 cites·4 claims
- 1983US8071579B2DNA damage repair inhibitors for the treatment of cancerASHWORTH ALAN·Filed 2004·Granted Dec 6, 2011·14 cites·11 claims
- 2083US7981890B2Phthalazinone derivativesASTRAZENECA AB·Filed 2008·Granted Jul 19, 2011·6 cites·6 claims
- 2183US7666870B2Phthalazinone derivativesMAYBRIDGE LTD·Filed 2008·Granted Feb 23, 2010·7 cites·5 claims
- 2282US7674823B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2007·Granted Mar 9, 2010·3 cites·7 claims
- 2381US2024245643A1DNA Damage Repair Inhibitors for Treatment of CancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2023·Application pending·0 cites
- 2479US11160803B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2019·Granted Nov 2, 2021·0 cites·9 claims
- 2577US7696203B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Apr 13, 2010·4 cites·9 claims
- 2672US2021244706A1DNA Damage Repair Inhibitors for Treatment of CancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2020·Application pending·0 cites
- 2771US7226918B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Jun 5, 2007·4 cites·9 claims
- 2870US7429660B2ATM inhibitorsKUDOS PHARM LTD·Filed 2004·Granted Sep 30, 2008·4 cites·12 claims
- 2970US7105518B2Thiopyrane-4-ones as DNA protein kinase inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Sep 12, 2006·5 cites·8 claims
- 3065US10034884B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2017·Granted Jul 31, 2018·0 cites·4 claims
- 3162US2017226124A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2017·Application pending·0 cites
- 3260US7902193B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2008·Granted Mar 8, 2011·0 cites·14 claims
- 3358US9717736B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2015·Granted Aug 1, 2017·0 cites·4 claims
- 3458US7732483B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2008·Granted Jun 8, 2010·0 cites·11 claims
- 3558US2009043091A1Atm inhibitorsKUDOS PHARM LTD·Filed 2008·Application pending·0 cites
- 3658US2023015617A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2021·Application pending·0 cites
- 3756US2017319543A1Dna damage repair inhibitors for treatment of cancerTHE INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL·Filed 2017·Application pending·0 cites
- 3856US2012135983A1DNA Damage Repair Inhibitors for the Treatment of CancerASHWORTH ALAN·Filed 2011·Application pending·0 cites
- 3952US2011130386A1Dna-pk inhibitorsFRIGERIO MARK·Filed 2009·Application pending·0 cites
- 4051US7642254B2ATM inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Jan 5, 2010·0 cites·3 claims
- 4150US2008280910A1Phthalazinone derivativesMENEAR KEITH ALLAN·Filed 2008·Application pending·0 cites
- 4247US2007049588A1Atm inhibitorKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 4347US2008255128A1Phthalazinone derivativesJAVAID MUHAMMAD HASHIM·Filed 2008·Application pending·0 cites
- 4447US2009023727A1Phthalazinone derivativesJAVAID MUHAMMAD HASHIM·Filed 2008·Application pending·0 cites
- 4546US2009181951A1Parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 4646US2009042865A1Dna-pk inhibitorsFRIGERIO MARK·Filed 2008·Application pending·0 cites
- 4746US2009281086A12 -oxyheteroarylamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 4846US2009209520A12 -oxybenzamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 4945US2008194546A1Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR InhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 5043US2012129855A1Phthalazinone derivativesMENEAR KEITH ALLAN·Filed 2012·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Niall Morrison Barr Martin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →